CFDE Data Portal | Search NBPF25P

	Label	Description
	NBPF25P associations Collection (Entity type)	Associations for NBPF25P_associations
	NBPF25P associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NBPF25P Gene (Entity type)	ENSG00000291005 - NBPF member 25, pseudogene
	GSE77108 saha 6 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 3 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 6 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 6 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE223893 SETD2 PARP inhibition kidney 4 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS

NBPF25P associations

Associations for NBPF25P_associations

NBPF25P associations.tsv

A file from IDG as part of the Harmonizome project

NBPF25P

ENSG00000291005 - NBPF member 25, pseudogene

GSE77108 saha 6 v 2 human dn

A Gene Set from LINCS

GSE143782 calcitriol 3 v 11 human dn

A Gene Set from LINCS

GSE77108 saha 5 v 2 human up

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human dn

A Gene Set from LINCS

GSE143782 calcitriol 6 v 5 human up

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 1 human dn

A Gene Set from LINCS

GSE223893 SETD2 PARP inhibition kidney 4 v 10 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.